Nonmotor Parkinson's: The Hidden Face

Management and the Hidden Face of Related Disorders

Specificaties
Gebonden, blz. | Engels
Elsevier Science | e druk, 2017
ISBN13: 9780128126035
Rubricering
Elsevier Science e druk, 2017 9780128126035
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Non-motor Parkinson's: The Hidden Face-Management and the Hidden Face of Related Disorders, Volume 134, the latest release in the International Review of Neurobiology series, is an up-to-date and comprehensive textbook addressing non-motor aspects of Parkinson’s disease, a key unmet need. Specific chapters in this updated release include Therapeutics and NMS in PD, Non-motor effects of conventional and transdermal therapies in PD, Infusion therapy, CDD and NMS in PD, DBS and NMS in PD, TMS and implications for NMS in PD, Botulinum toxin therapy and NMS in PD, and Nutrition and NMS in PD, amongst others.

Including practical tips for non-specialists and clinical algorithms, the book contains contributions from over 40 opinion leaders in the field of movement disorders. It provides practitioners and researchers with a laboratory, to bedside, to caregiver perspective.

Specificaties

ISBN13:9780128126035
Taal:Engels
Bindwijze:Gebonden

Inhoudsopgave

<p>Section 2B: Specific Nonmotor Symptoms in Parkinson’s Disease, Part 2</p> <p>25. Autonomic Dysfunction in Parkinson’s Disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms<br>26. The Gut and Nonmotor Symptoms in Parkinson’s Disease<br>27. Constipation in Parkinson’s Disease<br>28. Understanding and Treating Pain Syndromes in Parkinson’s Disease<br>29. Sexual Dysfunctions in Parkinson’s Disease: An Underrated Problem in a Much Discussed Disorder<br>30. Osteoporosis: A Hidden Nonmotor Face of Parkinson’s Disease<br>31. Weight in Parkinson’s Disease: Phenotypical Significance<br>32. Visual Dysfunction in Parkinson’s Disease<br>33. Nonmotor Fluctuations in Parkinson’s Disease<br>34. Acute Presentation of Nonmotor Symptoms<br>in Parkinson’s Disease</p> <p>Section 3: Therapeutics and Nonmotor Symptoms in Parkinson's Disease</p> <p>35. Nonmotor Effects of Conventional and Transdermal Dopaminergic Therapies in Parkinson’s Disease<br>36. Infusional Therapies, Continuous Dopaminergic Stimulation, and Nonmotor Symptoms<br>37. Deep Brain Stimulation and Nonmotor Symptoms<br>38. Noninvasive Brain Stimulation and Implications for Nonmotor Symptoms in Parkinson’s Disease<br>39. Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson’s Disease<br>40. Nutrition and Nonmotor Symptoms of Parkinson’s Disease<br>41. Complementary and Alternative Medicine and Exercise in Nonmotor Symptoms of Parkinson’s Disease<br>42. Speech, Voice, and Communication<br>43. Swallowing Dysfunctions in Parkinson’s Disease<br>44. Palliative Care and Nonmotor Symptoms in Parkinson’s Disease and Parkinsonism<br>45. Personalized Medicine and Nonmotor Symptoms in Parkinson’s Disease</p> <p>Section 4: Nonmotor Symptoms in Parkinsonism and Related Disorders</p> <p>46. Nonmotor Features in Atypical Parkinsonism<br>47. Nonmotor Symptoms in Vascular and Other Secondary Parkinsonism<br>48. Nonmotor Symptoms in Dystonia<br>49. Nonmotor Symptoms in Essential Tremor and Other Tremor Disorders<br>50. Nonmotor Symptoms in Huntington Disease<br>51. Nonmotor Symptoms in Amyotrophic Lateral Sclerosis: A Systematic Review<br>52. Nonmotor Manifestations of Wilson’s Disease<br>53. Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics</p> <p>Section 5: Nonmotor Parkinson's and Future Directions<br>54. Nonmotor Parkinson’s and Future Directions<br></p>

Rubrieken

Populaire producten

    Personen

      Trefwoorden

        Nonmotor Parkinson's: The Hidden Face